COVID-19
— AstraZeneca withdrawing its COVID vaccine from the market has nothing to do with blood clots.
Public health is the discipline that focuses on preventing disease, extending life, and enhancing well-being through the coordinated actions of society, both public and private entities, communities, and individuals.
COVID-19
— AstraZeneca withdrawing its COVID vaccine from the market has nothing to do with blood clots.
Public Health
— Welfare reforms targeted at the sick and disabled won’t boost government coffers. In fact, spending on those who need support and investing in less conditional systems has a real financial return.
What The Experts Say
— The expert reactions to the ongoing debate on the tobacco and vapes bill from distinguished scientists provide compelling arguments in favour of the proposed legislation.
COVID-19
— In its fourth year, a public health researcher outlines principles for a healthier future amid the COVID-19 pandemic: clear guidance, combating complacency, addressing inequalities, vaccine equity, and effective communication.
Healthcare
— The NHS faces critical challenges post-pandemic, with long waits and increasing privatisation. Though outsourcing may cut costs, a review reveals worse patient care and outcomes, advocating for public funding and management instead.
COVID-19
— Two new high-profile studies add to the increasingly worrisome picture of how even mild cases of COVID-19 can have detrimental effects on brain health.
COVID-19
— Privately selling COVID vaccines could boost immunity but raises worries about health inequalities. Affordability issues may limit access for lower-income individuals, worsening disparities in vaccine distribution.
Women
— Sexist and patronising language persists in UK obstetric care. Such language can contribute to dismissive treatment, undermining women’s perspectives and leading to interventions without consent or proper pain relief during childbirth.
2024 General Election
— Too often government policy is not designed with the long-term in mind. Instead, short-term economic outcomes and political gains are prioritised – to the detriment of public health.
COVID-19
— COVID remains a significant global health threat, causing 10,000 deaths in 50 countries and a 42% increase in hospitalisations in December 2023. Complacency poses risks.
COVID-19
— A new study published in the Biomedicine & Pharmacotherapy journal estimates that the use of hydroxychloroquine to treat COVID-19 was associated with nearly 17,000 deaths in six countries during the first wave of the pandemic.
COVID-19
— For a nation grappling with an invisible enemy, COVID-19, leadership became the compass, the difference between weathering the storm and succumbing to its fury. Yet, at the helm of the UK stood Boris Johnson, a man whose relationship with science resembled a blind date gone disastrously wrong.
COVID-19
— The ongoing COVID-19 wave has the potential to significantly grow, with the ONS estimating a 4.3% virus prevalence in England. One expert warns that the JN.1 wave might surpass the March 2022 surge.
COVID-19
— COVID-19 is experiencing a surge this winter in both England and Scotland. Prevalence is widespread, impacting all age groups, and increasing uncertainty in estimates across English regions, particularly in London and the South East.
COVID-19
— As the UK faces a surge in COVID-19 cases ahead of the festive season, concerns arise over the reliability of outdated lateral flow tests. Experts warn of compromised accuracy due to buffer liquid evaporation, urging individuals to check test expiration dates.
COVID-19
— In the ever-evolving game of COVID-19, a new challenger has entered the ring: JN.1, a viral upstart rapidly rising through the ranks and threatening to throw a winter curveball.
|